clopidogrel and Cardiac Diseases

clopidogrel has been researched along with Cardiac Diseases in 59 studies

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (40.68)	29.6817
2010's	32 (54.24)	24.3611
2020's	3 (5.08)	2.80

Authors

Authors	Studies
Farag, A; Hamabe, L; Mandour, AS; Matsumoto, K; Tanaka, R; Uemura, A; Yoshida, T	1
Colombo, A; Gallo, F; Giannini, F; Khokhar, AA; Laricchia, A; Mangieri, A; Sticchi, A	1
Masarova, L; Novak, J; Ondrasek, J; Panovsky, R; Pesl, M; Semenka, J; Simarova, E	1
Baschin, M; Diedrich, S; Greinacher, A; Hummel, A; Kohlmann, T; Schroeder, HW; Selleng, S; Thiele, T; Westphal, A	1
Fredgart, M; Gill, S	1
Chen, JY; Deng, CY; Fu, YH; Han, YL; Lei, HP; Li, XH; Lin, YB; Sheng, WS; Tang, QJ; Wu, H; Zhong, SL	1
Altındağ, R; Altıntaş, B; Baysal, E; Bilge, Ö; Burak, C; Ede, H; Karahan, MZ; Öztürk, Ö; Tanboğa, İH; Yaylak, B	1
Chen, Y; Chen, Z; Ge, J; Ma, J; Qian, J	1
Brizzio, M; Correll, M; Ferrari, G; Grau, JB; Johnson, CK; Mak, AW; Quackenbush, J; Shaw, RE; Zapolanski, A	1
D'Silva, A; Greenwood, J; Grosser, K; Jassim, I	1
Hurley, SP; Jacob, AK; Loughran, SM; Trousdale, RT; Wetsch, TM	1
Emanuelsson, H; Harrington, RA; James, SK; Katus, HA; Lewis, BS; Mahaffey, KW; Maurer, G; Meier, B; Steg, PG; Storey, RF; Wallentin, L; Wojdyla, DM	1
Cattaneo, M; Ottani, F	1
Caponi, G; Fava, CM; Favaloro, RR; Hidalgo Alava, GF; Lev, GA; Mendiz, OA; Valdivieso, LR	1
Godínez-Montes de Oca, A; Meléndez-Alcántara, MA; Mondragón-Terán, P; Robledo-Nolasco, R; Rubio-Guerra, AF; Suárez-Cuenca, JA; Zaballa-Contreras, JF	1
Chen, YF; Lin, CH; Lin, L; Lin, WW; Wang, CL; Wang, H	1
D'Ancona, G; Ince, H; Ketterer, U; Kische, S; Ortak, J; Siegel, I	1
Beattie, WS; Carroll, J; Grewal, D; Harsha, P; Karkouti, K; Ragoonanan, T; Starzyk, Ł; Syed, S; Travis, G; Wąsowicz, M; Wijeysundera, DN	1
Aribaş, A; Aygül, N; Can, I; Ozdemir, K	1
Boshoff, D; Eyskens, B; Gewillig, M; Mertens, L	1
Bauersachs, J; Eigenthaler, M; Schäfer, A	1
Selim, M	1
Buller, C; Densem, C; Fox, R; Fung, A; Jokhi, P; Mancini, GB; Ricci, D; Saw, J; Starovoytov, A; Walsh, S; Wong, G	1
Carro-Pagán, C; García-Rinaldi, R; McKellar, SH; Quiñones, J; Rodríguez-Acosta, JF; Schaff, HV; Thompson, JL	1
Erdem, G; Flather, MD; Geisler, T	1
Bergman, G; Feldman, DN; Minutello, RM; Moussa, I; Wong, SC	1
Gilchrist, IC	1
Chello, M; Colonna, D; Colonna, G; Covino, E; Di Sciascio, G; Montinaro, A; Pasceri, V; Patti, G; Pepe, LL	1
Lane, DA; Lip, GYH; Tapp, LD	1
Li, SH; Wang, ZH; Zhang, W; Zhang, Y; Zhao, HJ; Zheng, ZT; Zhong, M	1
Crimizade, U; El Adraa, E; El Ghannudi, S; Gachet, C; Jesel, L; Morel, O; Ohlmann, P; Radulescu, B; Wiesel, ML	1
Lerakis, S; Nam, D	1
Ana, G; António, F; Cardona, L; Cruz, FR; Leal, A; Lídia, S; Luísa, B	1
Grgurevich, S; Jacoski, MV; Jennings, LK; Li, JS; Michelson, AD; Tyagi, A	1
Angiolillo, DJ; Broderick, S; Buerke, M; Conley, PB; Dabrowski, M; Gurbel, PA; Harrington, RA; Jennings, LK; Kochman, J; McClure, MW; Neumann, FJ; Rao, SV; Saucedo, JF; Stephens, G; Stumpf, J; Trenk, D; Welsh, RC; Wójcik, J	1
Angiolillo, DJ; Berdan, LG; Bhatt, DL; French, WJ; Gibson, CM; Gretler, DD; Gurbel, PA; Harrington, RA; Huber, K; Kochman, J; Leonardi, S; Madan, M; McClure, MW; Paynter, G; Rao, SV; Thompson, VP; Welsh, RC; Zeymer, U	1
Montalescot, G; Silvain, J	1
de Caterina, R; Renda, G	1
Chen, SL; Lin, L; Lin, S; Tan, J; Wang, GJ; Xie, HG; Xu, HM; Zhang, J; Zhao, YY; Zou, JJ	1
Ackerstaff, RG; Breet, NJ; De Vries, JP; Deneer, VH; Elsenberg, EH; Hackeng, CM; Kelder, JC; Schonewille, WJ; Suttorp, MJ; Ten Berg, JM; Tromp, SC; Van Der Heyden, J; Van Neerven, D; Van Werkum, J; Vos, JA; Wolters, F	1
Ajani, AE; Bui, AB; Cheneau, E; Dieble, R; Kent, KK; Leborgne, L; Lindsay, J; Pichard, AD; Pinnow, E; Satler, LF; Waksman, R	1
Collart, F; Derouck, D; Feier, H; Kerbaul, F; Mesana, TG	1
Harrington, RA; Hodgson, PK; Larsen, RL	1
SoRelle, R	1
Ahnadi, CE; Boughrassa, FF; Chapman-Montgomery, ES; Gervais, A; Grant, AM; Okrongly, D; Poisson, V	1
Bonz, A; Eigenthaler, M; Grossmann, R; Lengenfelder, B; Obergfell, A; Porsche, C; Schnurr, A; Sokolova, O; Walter, U	1
Damkier, P; Hallas, J; Korsholm, L; Kristensen, SR; Mickley, H; Poulsen, TS; Vinholt, P	1
Harder, S; Klinkhardt, U	1
Bramkamp, M; Dedes, KJ; Szucs, TD	1
Alessi, MC; Bonnet, JL; Camoin, L; Cuisset, T; Frere, C; Lambert, M; Morange, PE; Quilici, J; Saut, N; Vague, IJ	1
Omeish, AF	1
Spiess, BD	1
van der Linden, J	1
Horowitz, J; Kaski, JC; McMurray, JJ; Recio-Mayoral, A; Remme, WJ; van Veldhuisen, DJ	1
Bauer, T; Gitt, A; Gottwik, M; Heer, T; Jünger, C; Koeth, O; Mark, B; Senges, J; Zahn, R; Zeymer, U	1

Reviews

10 review(s) available for clopidogrel and Cardiac Diseases

Article	Year
Dual antiplatelet therapy in coronary artery disease: from the past to the future prospective. Cardiovascular intervention and therapeutics, 2020, Volume: 35, Issue:2 Topics: Acute Coronary Syndrome; Anticoagulants; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Heart Diseases; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Risk Assessment; Ticagrelor	2020
Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis. Journal of clinical pharmacology, 2013, Volume: 53, Issue:5 Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Revascularization; Odds Ratio; Platelet Aggregation Inhibitors; Risk; Tetrazoles; Ticlopidine	2013
High maintenance dose of clopidogrel in patients with high on-treatment platelet reactivity after a percutaneous coronary intervention: a meta-analysis. Coronary artery disease, 2015, Volume: 26, Issue:5 Topics: Cerebrovascular Disorders; Chi-Square Distribution; Clopidogrel; Drug Resistance; Heart Diseases; Hemorrhage; Humans; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome	2015
[Clopidogrel--clinical use and potential therapeutic problems]. Herz, 2008, Volume: 33, Issue:4 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis; Clopidogrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Diseases; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Stents; Thrombosis; Ticlopidine	2008
What goes into a major acute coronary syndrome trial and what will future trials look like? Current cardiology reports, 2010, Volume: 12, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clinical Trials as Topic; Clopidogrel; Cyclic N-Oxides; Eptifibatide; Heart Diseases; Humans; Peptides; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Research Design; Research Support as Topic; Risk Factors; Sample Size; Thiophenes; Ticagrelor; Ticlopidine; United Kingdom	2010
"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment. Chest, 2011, Volume: 139, Issue:2 Topics: Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Stents; Stroke; Thromboembolism; Ticlopidine; Warfarin	2011
Impact of antiplatelet therapy in heart disease. Advances in cardiology, 2012, Volume: 47 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Heart Diseases; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Treatment Outcome	2012
The cost of new therapies in cardiovascular care. Time for hope or despair for developing countries. Saudi medical journal, 2007, Volume: 28, Issue:5 Topics: Cardiovascular Diseases; Clopidogrel; Developing Countries; Heart Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2007
Con: continuation of aspirin/clopidogrel for cardiac surgery. Journal of cardiothoracic and vascular anesthesia, 2007, Volume: 21, Issue:4 Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prognosis; Thrombosis; Ticlopidine	2007
Pro: continuation of aspirin/clopidogrel for cardiac surgery. Journal of cardiothoracic and vascular anesthesia, 2007, Volume: 21, Issue:4 Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prognosis; Thrombosis; Ticlopidine	2007

Trials

13 trial(s) available for clopidogrel and Cardiac Diseases

Article	Year
Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis. Journal of clinical pharmacology, 2013, Volume: 53, Issue:5 Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Revascularization; Odds Ratio; Platelet Aggregation Inhibitors; Risk; Tetrazoles; Ticlopidine	2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation, 2013, Sep-03, Volume: 128, Issue:10 Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Female; Follow-Up Studies; Heart Diseases; Humans; Internationality; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Stents; Ticagrelor; Ticlopidine; Treatment Outcome	2013
Efficacy of Change to New P2Y12 Receptor Antagonists in Patients High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2015, Volume: 21, Issue:7 Topics: Aged; Clopidogrel; Female; Heart Diseases; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Receptors, Purinergic P2Y12; Ticlopidine	2015
Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study. British journal of anaesthesia, 2016, Volume: 116, Issue:4 Topics: Aged; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Cohort Studies; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Surgical Procedures, Operative; Ticlopidine; Treatment Outcome; Troponin I	2016
The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Eptifibatide; Female; Heart Diseases; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Necrosis; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Ticlopidine; Time Factors; Treatment Outcome	2008
Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT Journal of cardiovascular medicine (Hagerstown, Md.), 2011, Volume: 12, Issue:3 Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Biomarkers; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Female; Heart Diseases; Humans; Italy; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Time Factors; Treatment Outcome; Troponin I	2011
Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: a comparative study of platelet aggregation response. Platelets, 2012, Volume: 23, Issue:6 Topics: Adenosine Diphosphate; Adult; Arteries; Blood Platelets; Child, Preschool; Clopidogrel; Double-Blind Method; Female; Fetal Blood; Heart; Heart Diseases; Humans; Infant; Infant, Newborn; Male; Peptide Fragments; Placebos; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine	2012
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (I Circulation. Cardiovascular interventions, 2012, Volume: 5, Issue:3 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Canada; Clopidogrel; Double-Blind Method; Drug Administration Schedule; Europe; Female; Heart Diseases; Humans; Injections, Intravenous; Male; Middle Aged; Models, Statistical; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Quinazolinones; Receptors, Purinergic P2Y12; Sulfonamides; Ticlopidine; Treatment Outcome; United States	2012
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PC Circulation. Cardiovascular interventions, 2012, Volume: 5, Issue:3 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Canada; Clopidogrel; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Europe; Female; Heart Diseases; Hemorrhage; Humans; Injections, Intravenous; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Quinazolinones; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Stroke; Sulfonamides; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; United States	2012
Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention. European journal of clinical pharmacology, 2013, Volume: 69, Issue:4 Topics: Adolescent; Adult; Aged; Aryl Hydrocarbon Hydroxylases; Asian People; China; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; DNA; Female; Genotype; Heart Diseases; Humans; Linear Models; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stents; Ticlopidine; Young Adult	2013
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial. The Journal of cardiovascular surgery, 2013, Volume: 54, Issue:3 Topics: Aged; Cardiac Surgical Procedures; Carotid Stenosis; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Eluting Stents; Female; Follow-Up Studies; Heart Diseases; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Ticlopidine; Ultrasonography, Doppler, Transcranial	2013
Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation, 2002, Aug-13, Volume: 106, Issue:7 Topics: Aspirin; Brachytherapy; Clopidogrel; Coronary Restenosis; Drug Administration Schedule; Female; Gamma Rays; Graft Occlusion, Vascular; Heart Diseases; Humans; Iridium Radioisotopes; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk; Stents; Ticlopidine; Time; Treatment Outcome	2002
Variable extent of clopidogrel responsiveness in patients after coronary stenting. Thrombosis and haemostasis, 2004, Volume: 92, Issue:6 Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cell Adhesion Molecules; Clopidogrel; Drug Therapy, Combination; Female; Flow Cytometry; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Diseases; Humans; Male; Membrane Proteins; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Ticlopidine; Treatment Outcome	2004

Other Studies

37 other study(ies) available for clopidogrel and Cardiac Diseases

Article	Year
Secondary right atrial thrombosis in three dogs: Antithrombotics therapy and echocardiographic follow-up. Veterinary medicine and science, 2023, Volume: 9, Issue:5 Topics: Animals; Atrial Fibrillation; Clopidogrel; Dog Diseases; Dogs; Echocardiography; Fibrinolytic Agents; Follow-Up Studies; Heart Atria; Heart Diseases; Rivaroxaban; Thrombosis	2023
Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report. BMC cardiovascular disorders, 2020, 02-21, Volume: 20, Issue:1 Topics: Aged; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Heart Atria; Heart Diseases; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve Annuloplasty; Mitral Valve Insufficiency; Platelet Aggregation Inhibitors; Recurrence; Rivaroxaban; Thrombectomy; Thrombosis; Treatment Outcome	2020
Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non-cardiac surgery: an observational cohort study. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Transfusion; Postoperative Hemorrhage; Preoperative Care; Retrospective Studies; Risk Assessment; Risk Factors; Surgical Procedures, Operative; Time Factors; Treatment Outcome	2018
Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel. BMJ case reports, 2018, May-30, Volume: 2018 Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Fatal Outcome; Heart Diseases; Heart Failure; Humans; Male; Thrombosis; Ticlopidine; Warfarin	2018
Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy. Acta pharmacologica Sinica, 2019, Volume: 40, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Clopidogrel; Coronary Artery Disease; Female; Heart Diseases; Hemorrhage; Humans; Male; MicroRNAs; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Vascular Diseases	2019
The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction. International journal of cardiology, 2019, 07-15, Volume: 287 Topics: Aged; Anterior Wall Myocardial Infarction; Aspirin; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Dual Anti-Platelet Therapy; Echocardiography; Female; Follow-Up Studies; Heart Diseases; Heart Ventricles; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Retrospective Studies; ST Elevation Myocardial Infarction; Thrombosis; Ticagrelor; Treatment Outcome; Turkey	2019
Mutational analysis clopidogrel resistance and platelet function in patients scheduled for coronary artery bypass grafting. Genomics, 2013, Volume: 101, Issue:6 Topics: Aged; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platelets; Case-Control Studies; Clopidogrel; Coronary Artery Bypass; Cytochrome P-450 CYP2C19; DNA Mutational Analysis; Drug Resistance; Female; Genetic Association Studies; Heart Diseases; Humans; Male; Middle Aged; Mutation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine	2013
Chasing the ACE of hearts. BMJ case reports, 2013, Jun-25, Volume: 2013 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clopidogrel; Drug Therapy, Combination; Electrocardiography; Female; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Sarcoidosis; Ticlopidine; Treatment Outcome	2013
Continuing clopidogrel during elective total hip and knee arthroplasty: assessment of bleeding risk and adverse outcomes. The Journal of arthroplasty, 2014, Volume: 29, Issue:2 Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Clopidogrel; Elective Surgical Procedures; Female; Heart Diseases; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Ticlopidine; Treatment Outcome	2014
[The ARCTIC study]. Giornale italiano di cardiologia (2006), 2013, Volume: 14, Issue:9 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug-Eluting Stents; Heart Diseases; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine	2013
Hybrid strategy for unstable patients with severe carotid and cardiac disease requiring surgery. Cardiology journal, 2015, Volume: 22, Issue:1 Topics: Aged; Angioplasty, Balloon; Anticoagulants; Aspirin; Cardiac Surgical Procedures; Carotid Artery Diseases; Clopidogrel; Female; Heart Diseases; Hemodynamics; Heparin; Hospital Mortality; Hospitals, High-Volume; Hospitals, University; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Stents; Ticlopidine; Time Factors; Treatment Outcome	2015
Percutaneous left atrial appendage occlusion: Device thrombosis in clopidogrel non-responders. International journal of cardiology, 2016, Feb-01, Volume: 204 Topics: Aged; Aged, 80 and over; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Female; Heart Diseases; Humans; Male; Middle Aged; Prosthesis Implantation; Thrombosis; Ticlopidine; Treatment Outcome; Ultrasonography	2016
Antiaggregant and anticoagulant therapy of free-floating thrombus in left atrium. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2008, Jun-07, Volume: 8, Issue:3 Topics: Adult; Anticoagulants; Aspirin; Clopidogrel; Diagnosis, Differential; Dyspnea; Echocardiography, Transesophageal; Female; Heart Atria; Heart Diseases; Heparin; Humans; Platelet Aggregation Inhibitors; Radiography; Thrombosis; Ticlopidine; Warfarin	2008
Safety and efficacy of clopidogrel in children with heart disease. The Journal of pediatrics, 2008, Volume: 153, Issue:1 Topics: Adolescent; Aspirin; Child; Child, Preschool; Clopidogrel; Female; Heart Diseases; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Warfarin	2008
Antiplatelets for stroke prevention: implications of the PRoFESS trial. Stroke, 2009, Volume: 40, Issue:5 Topics: Aspirin; Cerebral Hemorrhage; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine	2009
Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses. The Journal of heart valve disease, 2009, Volume: 18, Issue:6 Topics: Aged; Aortic Valve; Aspirin; Blood Platelets; Clopidogrel; Drug Combinations; Female; Follow-Up Studies; Heart Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Puerto Rico; Thromboembolism; Ticlopidine; United States	2009
Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Oct-01, Volume: 76, Issue:4 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antithrombins; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Diseases; Hemorrhage; Heparin; Hirudins; Hospital Mortality; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; New York City; Odds Ratio; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Propensity Score; Proportional Hazards Models; Recombinant Proteins; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2010
It is standard practice, but is it really best practice or clinical biocreep? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Oct-01, Volume: 76, Issue:4 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Antithrombins; Clopidogrel; Coronary Angiography; Drug Administration Schedule; Drug Therapy, Combination; Heart Diseases; Hemorrhage; Heparin; Hirudins; Hospital Mortality; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2010
What you need to know about Clopidogrel. This drug helps to prevent the blood clots that can cause heart attacks and stroke. Heart advisor, 2009, Volume: 12, Issue:8 Topics: Clopidogrel; Health Knowledge, Attitudes, Practice; Heart Diseases; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine	2009
Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat". Chest, 2011, Volume: 139, Issue:2 Topics: Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Stroke; Thromboembolism; Ticlopidine; Warfarin	2011
Protect your heart during dental work. Don't stop taking aspirin, Plavix, or any other antiplatelet before dental work without asking your cardiologist. Harvard heart letter : from Harvard Medical School, 2011, Volume: 21, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Dental Care for Chronically Ill; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2011
Impaired inhibition of P2Y(12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention. Atherosclerosis, 2011, Volume: 217, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cell Adhesion Molecules; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Resistance; Female; Flow Cytometry; France; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Microfilament Proteins; Middle Aged; Myocardial Infarction; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Registries; Risk Assessment; Risk Factors; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2011
The use of contrast echo to clear the left atrial appendage. Acute cardiac care, 2011, Volume: 13, Issue:2 Topics: Aspirin; Atrial Appendage; Clopidogrel; Contrast Media; Drug Therapy, Combination; Echocardiography; Echocardiography, Transesophageal; Fluorocarbons; Heart Atria; Heart Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine	2011
Thrombus formation on a left atrial appendage closure device. Circulation, 2011, Oct-04, Volume: 124, Issue:14 Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Equipment Design; Heart Diseases; Heparin; Humans; Male; Postoperative Complications; Septal Occluder Device; Thrombophilia; Thrombosis; Ticlopidine; Ultrasonography	2011
Rapid P2Y12 inhibition: still an unmet medical need. Circulation. Cardiovascular interventions, 2012, Volume: 5, Issue:3 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Female; Heart Diseases; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinazolinones; Receptors, Purinergic P2Y12; Sulfonamides; Ticlopidine	2012
Regression of intracardiac heparin-induced thrombosis after aortic root surgery. The Annals of thoracic surgery, 2003, Volume: 76, Issue:2 Topics: Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Follow-Up Studies; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin	2003
Cardiology patient page. Antiplatelet therapy. Circulation, 2003, Aug-19, Volume: 108, Issue:7 Topics: Aspirin; Blood Coagulation; Blood Platelets; Clopidogrel; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine	2003
Clopidogrel resistance marks recurrent risks. Circulation, 2004, Jun-29, Volume: 109, Issue:25 Topics: Aged; Bibliometrics; Cardiology; Clopidogrel; Cohort Studies; Coronary Restenosis; Drug Resistance; Estrogen Receptor alpha; Female; Folic Acid; Genetic Predisposition to Disease; Heart Diseases; Humans; Male; Mass Screening; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Platelet Aggregation Inhibitors; Predictive Value of Tests; Recurrence; Risk; Stents; Ticlopidine; Vitamin B 12; Vitamin B 6	2004
Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty. Thrombosis and haemostasis, 2004, Volume: 92, Issue:6 Topics: Abciximab; Aged; Angioplasty; Antibodies, Monoclonal; Blood Platelets; Cell Count; Clopidogrel; Edetic Acid; Female; Flow Cytometry; Fluorescent Dyes; Heart Diseases; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Risk; Ticlopidine; Time Factors	2004
Heart-protective drugs: a primer. Back to basics on how they work, side effects, interactions. Heart advisor, 2004, Volume: 7, Issue:12 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Calcium Channel Blockers; Clopidogrel; Diuretics; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2004
The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease. Thrombosis and haemostasis, 2005, Volume: 94, Issue:2 Topics: Aged; Atorvastatin; Blood Platelets; Cholesterol, LDL; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Simvastatin; Ticlopidine; Time Factors; Wound Healing	2005
Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function? Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:4 Topics: Adenosine Diphosphate; Adult; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clopidogrel; Flow Cytometry; Heart Diseases; Humans; Leukocytes; Male; Monocytes; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk; Ticlopidine	2005
Pharmacotherapy of acute coronary syndromes: medical economics with an emphasis on clopidogrel. Cardiovascular drugs and therapy, 2005, Volume: 19, Issue:4 Topics: Acute Disease; Clopidogrel; Cost-Benefit Analysis; Drug Costs; Economics, Medical; Fibrinolytic Agents; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Ticlopidine	2005
[When ASS, when anticoagulants?]. MMW Fortschritte der Medizin, 2006, Aug-17, Volume: 148, Issue:33-34 Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Clopidogrel; Female; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Sex Factors; Stroke; Ticlopidine; Time Factors	2006
Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome. Thrombosis research, 2007, Volume: 120, Issue:6 Topics: Acute Disease; Aged; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Drug Resistance; Electrocardiography; Female; Gene Frequency; Genotype; Heart Diseases; Heterozygote; Homozygote; Humans; Male; Microfilament Proteins; Middle Aged; P-Selectin; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine	2007
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6 Topics: Abciximab; Acute Coronary Syndrome; Amides; Antibodies, Monoclonal; Benzazepines; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Europe; Fumarates; Heart Diseases; Heart Failure; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptide Fragments; Probucol; Recombinant Proteins; Ticlopidine; Tolvaptan	2007
Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial. Thrombosis and haemostasis, 2008, Volume: 99, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Clopidogrel; Drug Therapy, Combination; Female; Heart Diseases; Hemorrhage; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Research Design; Retrospective Studies; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thrombolytic Therapy; Ticlopidine; Time Factors; Treatment Outcome	2008